Petro James B, Plasse Theodore R, McNulty Jack A
Counterproliferation and Technology Office, Defense Intelligence Agency, Bolling AFB, Washington, DC, USA.
Biosecur Bioterror. 2003;1(3):161-8. doi: 10.1089/153871303769201815.
Advances in biological research likely will permit development of a new class of advanced biological warfare (ABW) agents engineered to elicit novel effects. In addition, biotechnology will have applications supporting ABW weaponization, dissemination, and delivery. Such new agents and delivery systems would provide a variety of new use options, expanding the BW paradigm. Although ABW agents will not replace threats posed by traditional biological agents such as Bacillus anthracis (anthrax) and Variola (smallpox), they will necessitate novel approaches to counterproliferation, detection, medical countermeasures, and attribution.
